AstraZeneca Pharma India informs about redressal of investor complaints

16 Jan 2018 Evaluate

As required under Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed about the Report on Redressal of Investor Complaints for the quarter ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8405.75 51.30 (0.61%)
20-Mar-2026 12:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.75
Dr. Reddys Lab 1295.95
Cipla 1257.70
Zydus Lifesciences 890.90
Lupin 2319.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×